Article
Detection of mutations in EGFR in circulating lung-cancer cells.
The New England journal of medicine - 24 Jul 2008
Maheswaran Shyamala, Sequist Lecia V, Nagrath Sunitha, Ulkus Lindsey, Brannigan Brian, Collura Chey V, Inserra Elizabeth, Diederichs Sven, Iafrate A John, Bell Daphne W, Digumarthy Subba, Muzikansky Alona, Irimia Daniel, Settleman Jeffrey, Tompkins Ronald G, Lynch Thomas J, Toner Mehmet, Haber Daniel A
Abstract excerpt
BACKGROUND: The use of tyrosine kinase inhibitors to target the epidermal growth factor receptor gene (EGFR) in patients with non-small-cell lung cancer is effective but limited by the emergence of drug-resistance mutations. Molecular characterization of circulating tumor cells may provide a stra...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
